Reports of Practical Oncology最新文献

筛选
英文 中文
Direct photogeneration of singlet oxygen in biological medium for cancer therapy 生物介质中单线态氧的直接光生用于癌症治疗
Reports of Practical Oncology Pub Date : 2023-03-30 DOI: 10.31917/2401039
A. Bogdanov, A. Bogdanov, V. Klimenko, N. Verlov, V. Moiseyenko
{"title":"Direct photogeneration of singlet oxygen in biological medium for cancer therapy","authors":"A. Bogdanov, A. Bogdanov, V. Klimenko, N. Verlov, V. Moiseyenko","doi":"10.31917/2401039","DOIUrl":"https://doi.org/10.31917/2401039","url":null,"abstract":"Advances in cancer treatment require continuous improvement and the search for new therapies. Methods for direct photogeneration of singlet oxygen in tissue using IR lasers may be an effective alternative to photodynamic tumor therapy. The physical limitation for the direct photogeneration of singlet oxygen in a biological medium is the low absorption cross section of molecular oxygen. To overcome this limitation, it is necessary to use infrared radiation with a high power density, which in a living system is limited by thermal effects. A promising direction in the development of this approach could be the use of pulsed laser irradiation. By solving the problem of direct photogeneration of cytotoxic concentrations of singlet oxygen in a biological environment, including tumor tissue, without simultaneous heating to biocritical temperatures, it is possible to develop new effective and safe methods for the treatment of malignant neoplasms. Key words: single oxygen, direct photogeneration, reactive oxygen species, cancer therapy, photobiomodulation.","PeriodicalId":101072,"journal":{"name":"Reports of Practical Oncology","volume":"75 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83188815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stereotactic radiotherapy vs. surgery in the treatment of colorectal cancer liver oligometastases 立体定向放疗与手术治疗结直肠癌肝少转移的比较
Reports of Practical Oncology Pub Date : 2023-03-30 DOI: 10.31917/2401048
A. Moskalenko, V. Lyadov, D. G. Ichshanov, M. Chernykh, I. Sagaydak, M. R. Garipov, V. Galkin
{"title":"Stereotactic radiotherapy vs. surgery in the treatment of colorectal cancer liver oligometastases","authors":"A. Moskalenko, V. Lyadov, D. G. Ichshanov, M. Chernykh, I. Sagaydak, M. R. Garipov, V. Galkin","doi":"10.31917/2401048","DOIUrl":"https://doi.org/10.31917/2401048","url":null,"abstract":"Results There were no severe radiation-induced morbidity in the SBRT group, only 9,5% of patients developed grade 1 toxicity. In the surgery group complication rate was 18%, 1 lethal outcome was noted. The median follow-up was 24.6 months in the radiotherapy group and 22.8 months in the surgery group (p>0,05). 2 year LC rates was 62% in the SBRT group and 80% in the surgery group (p=0,019), and the 2-year OS was69.5% in the SBRT group and 84.7% in the surgery group (p = 0,03). The median mean dose was 54 Gy. Dose ≥51 Gy, was s a significant factor of improved local control. Conclusion SBRT is a safe and effective method of providing local control of colorectal cancer liver oligometastases. High-dose SBRT in hypofractionation regimen in selected patients with colorectal liver oligometastaseses comparable in terms of local control with surgery. Further studies are required to individualize the indications for this treatment method and optimize its methodology. Key words: Stereotactic radiation therapy, colorectal cancer, oligometastatic liver disease, hepatic resection","PeriodicalId":101072,"journal":{"name":"Reports of Practical Oncology","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79164554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibody-drug conjugates 抗体药物配合
Reports of Practical Oncology Pub Date : 2023-03-30 DOI: 10.31917/2401007
E. О. Stepanova, F. Moiseenko, V. Moiseyenko
{"title":"Antibody-drug conjugates","authors":"E. О. Stepanova, F. Moiseenko, V. Moiseyenko","doi":"10.31917/2401007","DOIUrl":"https://doi.org/10.31917/2401007","url":null,"abstract":"This article is a literature review of the available data on the history of origin, mechanism of action, and the main currently available conjugate-linked monoclonal antibodies. The use of conjugate-linked monoclonal antibodies in the therapy of both solid and hematological malignancies is a promising direction of anti-tumor therapy.","PeriodicalId":101072,"journal":{"name":"Reports of Practical Oncology","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90162352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world evidence studies in oncology: a trend or a necessity? 肿瘤学的真实世界证据研究:趋势还是必要?
Reports of Practical Oncology Pub Date : 2023-03-30 DOI: 10.31917/2401059
А.А. Zhuravkov, F. Moiseenko, A. Kolbin, V. Moiseyenko
{"title":"Real-world evidence studies in oncology: a trend or a necessity?","authors":"А.А. Zhuravkov, F. Moiseenko, A. Kolbin, V. Moiseyenko","doi":"10.31917/2401059","DOIUrl":"https://doi.org/10.31917/2401059","url":null,"abstract":"Key words: real-world data, RWD, randomized clinical trial, oncology.","PeriodicalId":101072,"journal":{"name":"Reports of Practical Oncology","volume":"67 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77242817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oncologic surgery in the era of drug therapy 药物治疗时代的肿瘤外科
Reports of Practical Oncology Pub Date : 2023-03-30 DOI: 10.31917/2401027
{"title":"Oncologic surgery in the era of drug therapy","authors":"","doi":"10.31917/2401027","DOIUrl":"https://doi.org/10.31917/2401027","url":null,"abstract":"Surgical oncology has undergone a number of tactical changes in the era of the development of drug therapy, but is still the only treatment that can cure most solid forms of cancer. Recently, surgical interventions are increasingly acquiring an individual approach to the patient. Surgical oncology is part of a multifaceted multidisciplinary team with a single philosophy in understanding the biology of tumor development, as well as the contribution of other disciplines to the treatment of cancer patients. Key words: surgical oncology, cytoreductive surgery, intraoperative chemotherapy.","PeriodicalId":101072,"journal":{"name":"Reports of Practical Oncology","volume":"103 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88981198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SURGICAL RESULTS OF LUNG CANCER TREATMENT IT PATIENTS WITH CONCOMITANT CORONARY ARTERY DISEAS 肺癌合并冠状动脉疾病的手术疗效分析
Reports of Practical Oncology Pub Date : 2023-03-30 DOI: 10.31917/2401080
S. Gerasimov, M. V. Serebryanskaya, M. Davydov, R. Akchurin, Y. Buziashvili, E. Golubev, E. Charchyan, D. V. Puzenko, P. Kononets
{"title":"SURGICAL RESULTS OF LUNG CANCER TREATMENT IT PATIENTS WITH CONCOMITANT CORONARY ARTERY DISEAS","authors":"S. Gerasimov, M. V. Serebryanskaya, M. Davydov, R. Akchurin, Y. Buziashvili, E. Golubev, E. Charchyan, D. V. Puzenko, P. Kononets","doi":"10.31917/2401080","DOIUrl":"https://doi.org/10.31917/2401080","url":null,"abstract":"Results: the incidence of postoperative complications was 33,8% (22/65), mortality – 3,1% (2/65); with phased tactics, these figures were 31,7% (19/60) and 3,3% (2/60); after simultaneous operations – 60% (3/5) and 0%, respectively. When performing operations for lung cancer after preliminary myocardial revascularization, the incidence of postoperative myocardial infarction was 3,3% (2/63), with a fatal outcome of 1,6% (1/63). In the long term, the total 1-, 3- and 5-year survival rate of radically operated patients was: at stage I – 95,7%, 86,3%, 64,7%, with II – 82,6%, 62,4%, 49,9% and at III – 66,0%, 55,8% and 34,3%, respectively (p = 0,042). Conclusions: the implementation of prophylactic myocardial revascularization in patients with lung cancer with severe forms of concomitant coronary artery disease allows to expand the group of radically operated patients, to achieve satisfactory immediate and long-term treatment results. Key words: lung cancer, coronary artery disease, lobectomy, bilobectomy, pneumonectomy, coronary artery bypass surgery, coronary angioplasty","PeriodicalId":101072,"journal":{"name":"Reports of Practical Oncology","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82353801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor-infiltrating lymphocytes – from theory to real practice 肿瘤浸润淋巴细胞——从理论到实践
Reports of Practical Oncology Pub Date : 2023-03-30 DOI: 10.31917/2401019
{"title":"Tumor-infiltrating lymphocytes – from theory to real practice","authors":"","doi":"10.31917/2401019","DOIUrl":"https://doi.org/10.31917/2401019","url":null,"abstract":"Adoptive therapy with tumor-infiltrating lymphocytes (TIL) has been studied since 1980s. Although some trials showed very high efficacy in melanoma and other tumors no enough data were available for approval of the method perhaps due to the cost, complexity and reproducibility limited to academic centers. Last year the results of prospective phase III trial comparing TIL therapy to standard immunotherapy for melanoma were reported which proved the efficacy and even superiority of the method. This paper reviews the principles of adoptive TIL therapy and the perspectives for further developement.","PeriodicalId":101072,"journal":{"name":"Reports of Practical Oncology","volume":"421 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78118422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer evolution as a new target of treatment paradigm 肿瘤进化作为治疗范式的新靶点
Reports of Practical Oncology Pub Date : 2023-03-30 DOI: 10.31917/2401033
V. Chubenko
{"title":"Cancer evolution as a new target of treatment paradigm","authors":"V. Chubenko","doi":"10.31917/2401033","DOIUrl":"https://doi.org/10.31917/2401033","url":null,"abstract":"In clinical practice, the cancer treatment is certainly resulted from the biology of tumor growth, the modern understanding of which is based on the theory of genetic changes. In this regard, the effective strategy is the research and target on trigger mutations in the tumor. Obviously, a malignant neoplasm is the set of the different populations of epithelial, stromal and immune cells as well as intercellular matrix with dynamically changing blood flow, nutrients, acid-base state and oxygen concentration, which is almost not taken into account by clinicians.","PeriodicalId":101072,"journal":{"name":"Reports of Practical Oncology","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86734906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LIQUID BIOPSY IN CLINICAL ONCOLOGY 临床肿瘤学液体活检
Reports of Practical Oncology Pub Date : 2022-12-30 DOI: 10.31917/2304211
E. Imyanitov, E. Kuligina, G. Januś
{"title":"LIQUID BIOPSY IN CLINICAL ONCOLOGY","authors":"E. Imyanitov, E. Kuligina, G. Januś","doi":"10.31917/2304211","DOIUrl":"https://doi.org/10.31917/2304211","url":null,"abstract":"Liquid biopsy is the analysis of tumor fragments (entire cells, nucleic acids,proteins) in hysiological and pathological body liquids. This technology has already been included in standard procedures of detecting secondary mutations, which are associate with acquired drug resistance. Liquid biopsy is a promising tool for early cancer detection, evaluation of the success of radical cancer surgery, monitoring of residual tumor disease, assessment of treatment efficacy etc.","PeriodicalId":101072,"journal":{"name":"Reports of Practical Oncology","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81469982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OPPORTUNITIES AND PROSPECTS OF ARTIFICIAL INTELLIGENCE IN THE PATHOLOGICAL IDENTIFICATION OF CANCER 人工智能在癌症病理鉴定中的机遇与前景
Reports of Practical Oncology Pub Date : 2022-12-30 DOI: 10.31917/2304234
K. Shelekhova
{"title":"OPPORTUNITIES AND PROSPECTS OF ARTIFICIAL INTELLIGENCE IN THE PATHOLOGICAL IDENTIFICATION OF CANCER","authors":"K. Shelekhova","doi":"10.31917/2304234","DOIUrl":"https://doi.org/10.31917/2304234","url":null,"abstract":"Digitalization, artificial intelligence and machine learning are increasingly being introduced into medicine and pathology in particular. The review presents the definitions and modern concepts of this field, the possibilities and limitations, the advantages and disadvantages of their use. Examples from representative publications are discussed.","PeriodicalId":101072,"journal":{"name":"Reports of Practical Oncology","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88073078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信